Sphingolipid synthases of toxoplasma gondii and other organisms
Sphingolipid synthases of toxoplasma gondii and other organisms
Toxoplasma gondii is an obligate intracellular protozoan parasite of the phylum Apicomplexa, and toxoplasmosis is an important disease in immuno-compromised individuals - especially AIDS patients, organ transplant recipients and patients receiving anti-cancer chemotherapy. Toxoplasmosis also has economic importance as it results in spontaneous abortion in economically important animals. Due to emerging drug resistance and the possible side effects of the existing therapeutics there is a necessity to explore new drug targets. Sphingolipids are essential components of eukaryotic cell membranes and signal transduction pathways. Mammals produce sphingomyelin (SM) via a SM synthase, whereas yeast, plants and some protozoa utilise an inositol phosphorylceramide (IPC) synthase to produce IPC. IPC synthases have no mammalian equivalent and have been proposed as targets for anti-fungals and anti-protozoals. In this study sphingolipid scavenging from the host was shown to be non-essential for Toxoplasma proliferation indicating de novo synthesis is key. To investigate this pathway in the parasite an orthologue of the SM synthase from the related apicomplexan Plasmodium falciparum was identified in the genome database as being encoded by a single copy gene. Subsequently it was characterized as a functional orthologue of the yeast AUR1p (IPC synthase), with mass spectrometry identifying this lipid species in parasite extracts for the first time. Like AUR1p and the human SM synthase, the Toxoplasma sphingolipid synthase (Tg SLS) is Golgi localized. However, unlike AUR1p Tg SLS is resistant to the inhibitor aureobasidin A and also facilitates production of a minor complex sphingolipid suggested to be SM. Further study characterized the sphingolipid synthases from the Trypanosoma species (protozoan Kinetoplastida) and the plant Arabidopsis. Bioinformatic and phylogenetic analyses of these and previously characterized SM and IPC synthases, indicate them to be a family of evolutionarily related, but functionally diverse, enzymes. Many of these may prove to be targets for pharmaceutical or herbicidal intervention.
Wansadhipathi Kannangara, Nilu Kumari
a2c031cf-a6b1-4ccf-af88-c41cedda3c00
19 October 2011
Wansadhipathi Kannangara, Nilu Kumari
a2c031cf-a6b1-4ccf-af88-c41cedda3c00
Wansadhipathi Kannangara, Nilu Kumari
(2011)
Sphingolipid synthases of toxoplasma gondii and other organisms.
Durham University, Biophysical Sciences Institute, Doctoral Thesis.
Record type:
Thesis
(Doctoral)
Abstract
Toxoplasma gondii is an obligate intracellular protozoan parasite of the phylum Apicomplexa, and toxoplasmosis is an important disease in immuno-compromised individuals - especially AIDS patients, organ transplant recipients and patients receiving anti-cancer chemotherapy. Toxoplasmosis also has economic importance as it results in spontaneous abortion in economically important animals. Due to emerging drug resistance and the possible side effects of the existing therapeutics there is a necessity to explore new drug targets. Sphingolipids are essential components of eukaryotic cell membranes and signal transduction pathways. Mammals produce sphingomyelin (SM) via a SM synthase, whereas yeast, plants and some protozoa utilise an inositol phosphorylceramide (IPC) synthase to produce IPC. IPC synthases have no mammalian equivalent and have been proposed as targets for anti-fungals and anti-protozoals. In this study sphingolipid scavenging from the host was shown to be non-essential for Toxoplasma proliferation indicating de novo synthesis is key. To investigate this pathway in the parasite an orthologue of the SM synthase from the related apicomplexan Plasmodium falciparum was identified in the genome database as being encoded by a single copy gene. Subsequently it was characterized as a functional orthologue of the yeast AUR1p (IPC synthase), with mass spectrometry identifying this lipid species in parasite extracts for the first time. Like AUR1p and the human SM synthase, the Toxoplasma sphingolipid synthase (Tg SLS) is Golgi localized. However, unlike AUR1p Tg SLS is resistant to the inhibitor aureobasidin A and also facilitates production of a minor complex sphingolipid suggested to be SM. Further study characterized the sphingolipid synthases from the Trypanosoma species (protozoan Kinetoplastida) and the plant Arabidopsis. Bioinformatic and phylogenetic analyses of these and previously characterized SM and IPC synthases, indicate them to be a family of evolutionarily related, but functionally diverse, enzymes. Many of these may prove to be targets for pharmaceutical or herbicidal intervention.
This record has no associated files available for download.
More information
Published date: 19 October 2011
Organisations:
Faculty of Medicine
Identifiers
Local EPrints ID: 373061
URI: http://eprints.soton.ac.uk/id/eprint/373061
PURE UUID: 6256241e-be35-40b6-ab42-fb35339e4b53
Catalogue record
Date deposited: 17 Feb 2016 11:46
Last modified: 08 Nov 2022 18:21
Export record
Contributors
Author:
Nilu Kumari Wansadhipathi Kannangara
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics